DALLA MAN, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.993
AS - Asia 2.292
EU - Europa 2.254
AF - Africa 18
SA - Sud America 17
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.934
CN - Cina 951
SG - Singapore 891
IT - Italia 587
FI - Finlandia 387
FR - Francia 285
SE - Svezia 277
VN - Vietnam 267
DE - Germania 212
GB - Regno Unito 174
UA - Ucraina 87
IN - India 64
NL - Olanda 52
IE - Irlanda 45
KR - Corea 37
ES - Italia 36
CA - Canada 32
RU - Federazione Russa 32
CH - Svizzera 26
MX - Messico 26
TR - Turchia 19
HK - Hong Kong 14
DK - Danimarca 11
JP - Giappone 11
IR - Iran 10
EU - Europa 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
AU - Australia 7
DZ - Algeria 7
CO - Colombia 6
SA - Arabia Saudita 6
AT - Austria 5
BG - Bulgaria 5
GR - Grecia 5
AR - Argentina 4
BE - Belgio 4
ID - Indonesia 4
IL - Israele 4
PK - Pakistan 4
ZA - Sudafrica 4
EC - Ecuador 3
LT - Lituania 3
RO - Romania 3
TH - Thailandia 3
CL - Cile 2
HU - Ungheria 2
IQ - Iraq 2
MA - Marocco 2
NG - Nigeria 2
RS - Serbia 2
SI - Slovenia 2
UY - Uruguay 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
GH - Ghana 1
KE - Kenya 1
LB - Libano 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 20.599
Salva come PNG Salva come JPEG
Città #
Fairfield 2.383
Woodbridge 1.667
Houston 1.395
Ann Arbor 1.325
Chandler 1.192
Ashburn 934
Seattle 829
Wilmington 785
Cambridge 771
Singapore 712
Boardman 485
Santa Clara 475
Jacksonville 441
Princeton 355
Roxbury 281
Dong Ket 263
San Diego 259
Medford 252
Des Moines 201
Beijing 176
Nanjing 175
Helsinki 167
Padova 154
Guangzhou 138
Shenyang 58
Shanghai 54
Nanchang 53
Hebei 50
Dublin 40
Rome 35
London 30
Jiaxing 29
Irapuato 25
Milan 25
Frankfurt am Main 24
Ithaca 23
Norwalk 23
Falls Church 22
Pohang 22
Charlottesville 21
Ogden 21
Changsha 20
Redwood City 20
Valencia 20
New York 19
Tianjin 19
Jinan 16
New Delhi 16
Treviso 16
Arzignano 15
Southwark 15
Bagnolet 13
Chicago 13
Falkenstein 13
Hong Kong 13
Los Angeles 13
Ulsan 13
Borås 12
Paese 12
Yenibosna 12
Lappeenranta 11
Birmingham 10
Munich 10
Ningbo 10
Eindhoven 9
Kharkiv 9
Oxford 9
Verona 9
Belluno 8
Kilburn 8
Montreal 8
Paris 8
Zurich 8
Bern 7
Florence 7
Hamilton 7
Hefei 7
Minneapolis 7
New Haven 7
Vicenza 7
Zhengzhou 7
Bagnaria Arsa 6
Bristol 6
Chiswick 6
Freiburg im Breisgau 6
Islington 6
Kunming 6
Mannheim 6
Nogara 6
Redlands 6
Toronto 6
Trieste 6
Turin 6
Acton 5
Amsterdam 5
Bengaluru 5
Coimbatore 5
Croissy-Beaubourg 5
Nanto 5
Oslo 5
Totale 16.940
Salva come PNG Salva come JPEG
Nome #
A system model of oral glucose absorption: Validation on gold standard data 159
Increased Rates of Meal Absorption Do Not Explain Elevated 1-Hour Glucose in Subjects With Normal Glucose Tolerance 150
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 140
In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes 140
Circadian variability of insulin sensitivity: Physiological input for in silico artificial pancreas 132
Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production. 130
A dynamic risk measure from continuous glucose monitoring data. 129
Multiscale Modeling of Insulin Secretion 127
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach 126
Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes 126
The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. 123
Downregulation of the Longevity-Associated Protein SIRT1 in Insulin Resistance and Metabolic Syndrome. Potential Biochemical Mechanisms 122
Meal simulation model of the glucose-insulin system 120
A model of GLP-1 action on insulin secretion in nondiabetic subjects. 119
Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. 118
Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function 118
The UVA/PADOVA Type 1 Diabetes Simulator: New Features. 117
Smart Insulin Therapy Initiation In Insulin-Naive Subjects With Type 2 Diabetes Using Machine Learning 116
The University of Virginia/Padova Type 1 Diabetes Simulator Matches the Glucose Traces of a Clinical Trial 115
An index of parameter reproducibility accounting for estimation uncertainty: Theory and case study on β-cell responsivity and insulin sensitivity 115
Age-Related Changes in Insulin Sensitivity and β-Cell Function Among European-American and African-American Women. 114
Assessment of pulsatile insulin secretion derived from peripheral plasma c-peptide concentrations by nonparametric stochastic deconvolution 114
Adiposity and β-cell function: relationships differ with ethnicity and age. 112
Advancing Our Understanding of the Glucose System via Modeling: A Perspective. 112
1054-P: Insulin Sensitivity from Sensor and Pump Data in Youths with Type 1 Diabetes: Hybrid Closed-Loop Validation 112
MPC based Artificial Pancreas: Strategies for individualization and meal compensation 111
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men 110
Modular Closed-Loop Control of Diabetes. 110
Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method 109
DHEA in elderly women and DHEA or testosterone in elderly men 109
Intranasal oxytocin fails to acutely improve glucose metabolism in obese men 108
Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training 107
Diabetes: Models, Signals, and Control. 106
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. 106
Adjustment of open-loop settings to improve closed-loop results in type 1 diabetes: A multicenter randomized trial 106
Effects of the Novel Dual GLP-1R/GCGR Agonist SAR425899 on Postprandial Glucose Metabolism in Overweight/Obese Subjects with Type 2 Diabetes 106
Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes. 106
Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB) 105
Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content 104
Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction 103
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia. 103
Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. 102
Exercise effects on postprandial glucose metabolism in type 1 diabetes: A triple-tracer approach 102
Association between thyrotropin levels and insulin sensitivity in euthyroid obese adolescents 102
Model-Based Quantification of Glucagon-Like Peptide-1-Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge 102
A Model for the Estimation of Hepatic Insulin Extraction after a Meal 101
Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids 101
Race differences in the association of oxidative stress with insulin sensitivity in African- and European-American women. 100
Ethnic differences in insulin sensitivity, β-cell function, and hepatic extraction between Japanese and Caucasians: a minimal model analysis. 100
Impaired Insulin Action is Associated with Increased Glucagon Concentrations in Non-Diabetic Humans 100
One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator 100
Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes. 98
The oral glucose minimal model: estimation of insulin sensitivity from a meal test 98
Co-occurrence of Risk Alleles in or Near Genes Modulating Insulin Secretion Predisposes Obese Youth to Prediabetes 98
Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data 97
Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose: Insight from an in Silico study 97
Insulin sensitivity by oral glucose minimal models: validation against clamp 96
Epicardial and Pericardial Fat in Type 2 Diabetes: Favourable Effects of Biliopancreatic Diversion 96
Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass 95
Glucose metabolism during rotational shift-work in healthcare workers 95
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator ∗ 95
In Silico Optimization of Basal Insulin Infusion Rate during Exercise: Implication for Artificial Pancreas. 94
Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function and Glucose Metabolism in Non-Diabetic Subjects. 93
Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. 93
Postprandial Glucose Fluxes and Insulin Sensitivity during Exercise:A Study in Healthy Individuals 92
The effect of a bile Acid sequestrant on glucose metabolism in subjects with type 2 diabetes. 92
Hepatic insulin sensitivity in healthy and prediabetic subjects: From a dual- to a single-tracer oral minimal model 92
Model Predictive Control of Type 1 Diabetes: An In Silico Trial 91
Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness and Postprandial Glucose Metabolism 91
Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes? 90
Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling. 90
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. 90
A Model of GLP-1 Action on Insulin Secretion in Nondiabetic Subjects 90
Modeling Hepatic Insulin Sensitivity during a Meal: Validation against the Euglycemic-Hyperinsulinemic Clamp. 89
The Padova Type 2 Diabetes Simulator from Triple-Tracer Single-Meal Studies: In Silico Trials Also Possible in Rare but Not-So-Rare Individuals 89
Effects of Hyperglycemia and Hyperinsulinemia on Glucose Turnover during Exercise in Type 1 Diabetes 89
Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women 87
Acute Insulin Resistance and Insulin Secretion in Glucose Tolerant and Intolerant Subjects With and Without Diabetes-associated Variation in TCF7L2 86
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial 86
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. 86
Prediction of postprandial glycemic exposure: utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength 85
Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model 84
Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. 84
A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. 84
Mechanism of Insulin Resistance in Normal Pregnancy. 84
Diurnal Pattern to Insulin Secretion and Insulin Action in Healthy Individuals 84
Physical Activity Measured by Physical Activity Monitoring System Correlates with Glucose Trends Reconstructed from Continuous Glucose Monitoring 84
Effect of pramlintide on postprandial glucose fluxes in type 1 diabetes 84
Differential effects of the circadian system and circadian misalignment on insulin sensitivity and insulin secretion in humans 84
Use of labeled oral minimal model to measure hepatic insulin sensitivity. 84
Smart Titration of Long-Acting Insulin in Insulin-Naïve Type 2 Diabetic Subjects 83
Diurnal Pattern of Insulin Action in Type 1 diabetes: Implications for a Closed Loop System. 83
Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans 83
The Oral Minimal Model Method 82
Glucose fluxes during OGTT in adolescents assessed by a stable isotope triple tracer method 81
Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator 81
Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis 81
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes 80
Model Predictive Control of Type 1 diabetes added to conventional therapy 80
The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects 80
Totale 10.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.440
article - articoli 53.410
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 616
selected - selezionate 0
volume - volumi 744
Totale 135.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.574 0 0 0 0 0 0 282 363 341 296 164 128
2020/20212.837 104 176 74 163 107 335 130 183 421 208 365 571
2021/20223.728 101 539 436 209 129 261 189 375 161 78 315 935
2022/20232.532 610 201 149 203 422 261 6 151 328 37 123 41
2023/20241.758 122 250 162 145 79 82 124 82 71 240 191 210
2024/20252.522 115 600 317 226 1.057 201 6 0 0 0 0 0
Totale 20.896